Xylem Inc. $XYL Stock Position Decreased by Gamco Investors INC. ET AL

Gamco Investors INC. ET AL decreased its holdings in shares of Xylem Inc. (NYSE:XYL) by 6.2% during the 1st quarter, Holdings Channel.com reports. The fund owned 327,951 shares of the industrial products company’s stock after selling 21,621 shares during the period. Gamco Investors INC. ET AL’s holdings in Xylem were worth $39,190,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently bought and sold shares of the company. Callahan Advisors LLC bought a new position in shares of Xylem during the fourth quarter worth about $1,721,000. Northwestern Mutual Wealth Management Co. lifted its position in Xylem by 2,309.7% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 431,824 shares of the industrial products company’s stock valued at $54,314,000 after purchasing an additional 413,904 shares during the last quarter. Abacus Wealth Partners LLC acquired a new position in Xylem during the 4th quarter valued at about $1,663,000. Boston Common Asset Management LLC boosted its stake in Xylem by 15.3% during the 4th quarter. Boston Common Asset Management LLC now owns 143,740 shares of the industrial products company’s stock valued at $19,575,000 after purchasing an additional 19,073 shares during the period. Finally, Norges Bank bought a new position in Xylem in the 4th quarter worth about $361,012,000. Institutional investors own 87.96% of the company’s stock.

Insider Activity at Xylem

In other Xylem news, CAO Geri-Michelle Mcshane sold 4,269 shares of the company’s stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $117.46, for a total value of $501,436.74. Following the completion of the sale, the chief accounting officer directly owned 3,605 shares in the company, valued at $423,443.30. This represents a 54.22% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Jerome A. Peribere purchased 1,210 shares of the firm’s stock in a transaction on Monday, May 4th. The shares were purchased at an average cost of $116.61 per share, with a total value of $141,098.10. Following the completion of the purchase, the director owned 27,209 shares in the company, valued at $3,172,841.49. This represents a 4.65% increase in their position. The disclosure for this purchase is available in the SEC filing. 0.32% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

XYL has been the topic of several analyst reports. Stifel Nicolaus dropped their price target on shares of Xylem from $159.00 to $157.00 and set a “buy” rating on the stock in a research note on Monday. Oppenheimer reduced their price objective on Xylem from $160.00 to $158.00 and set an “outperform” rating for the company in a research report on Wednesday, April 29th. Jefferies Financial Group raised Xylem from a “hold” rating to a “buy” rating and increased their price objective for the stock from $130.00 to $140.00 in a report on Thursday, June 25th. Citigroup lowered their target price on Xylem from $174.00 to $168.00 and set a “buy” rating on the stock in a research report on Wednesday, April 29th. Finally, Weiss Ratings downgraded Xylem from a “hold (c+)” rating to a “hold (c)” rating in a research note on Friday, May 8th. Eight equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat, Xylem has an average rating of “Moderate Buy” and a consensus target price of $153.15.

Xylem Stock Up 2.4%

Xylem stock opened at $119.66 on Friday. The stock has a market cap of $28.44 billion, a price-to-earnings ratio of 29.77, a PEG ratio of 1.66 and a beta of 1.03. The company has a current ratio of 1.46, a quick ratio of 1.10 and a debt-to-equity ratio of 0.13. The company’s 50-day moving average price is $114.04 and its two-hundred day moving average price is $122.82. Xylem Inc. has a 52 week low of $105.29 and a 52 week high of $154.27.

Xylem (NYSE:XYL) last issued its quarterly earnings results on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share for the quarter, topping analysts’ consensus estimates of $1.09 by $0.03. The company had revenue of $2.12 billion during the quarter, compared to analyst estimates of $2.11 billion. Xylem had a net margin of 10.79% and a return on equity of 11.26%. The business’s revenue for the quarter was up 2.7% compared to the same quarter last year. During the same period in the prior year, the business posted $1.03 EPS. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. On average, analysts expect that Xylem Inc. will post 5.52 EPS for the current fiscal year.

Xylem Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, June 25th. Investors of record on Thursday, May 28th were issued a dividend of $0.43 per share. The ex-dividend date of this dividend was Thursday, May 28th. This represents a $1.72 annualized dividend and a yield of 1.4%. Xylem’s payout ratio is presently 42.79%.

About Xylem

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.